JCI vs MBX · P/E 44, rev $23.60B vs $1.98B cap
Johnson Controls International PLC (JCI) versus MBX Biosciences, Inc. Common Stock (MBX) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
MBX does not have a complete income-statement cache yet.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. MBX currently screens at market cap $1.98B.
Not investment advice. Open the JCI and MBX stock pages for the full models.
Not investment advice.